Inflammatory conditions, i.e., ulcerative colitis (UC) and Crohn’s disease (CD), demonstrate that mTOR activity in IECs is activated by microbial-derived pathogen-associated molecular patterns (PAMPs), thereby exacerbating inflammation [56]. Here, MTOR is linked to ulcerative colitis.